Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -103,270 | -52,553 | -17,348 | N/A | N/A |
| Depreciation Amortization | 623 | -2 | N/A | N/A | N/A |
| Other Working Capital | 611 | 7,123 | 2,437 | N/A | N/A |
| Other Operating Activity | 12,961 | 6,070 | 14,538 | 0 | 0 |
| Operating Cash Flow | $-89,075 | $-39,362 | $-373 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 38,099 | -127,500 | 0 | N/A | N/A |
| PPE Investments | -225 | -281 | -7,500 | N/A | N/A |
| Investing Cash Flow | $37,874 | $-127,781 | $-7,500 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 50 | N/A | N/A |
| Common Stock Issued | 131,871 | 67,200 | 1 | N/A | N/A |
| Other Financing Activity | 49,417 | 59,977 | 59,785 | 0 | 0 |
| Financing Cash Flow | $181,288 | $127,177 | $59,836 | $N/A | $N/A |
| Exchange Rate Effect | 29 | -27 | 0 | N/A | N/A |
| Beginning Cash Position | 11,970 | 51,963 | 0 | N/A | N/A |
| End Cash Position | 142,086 | 11,970 | 51,963 | N/A | N/A |
| Net Cash Flow | $130,116 | $-39,993 | $51,963 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -89,075 | -39,362 | -373 | N/A | N/A |
| Capital Expenditure | -225 | -281 | -7,500 | N/A | N/A |
| Free Cash Flow | -89,300 | -39,643 | -7,873 | 0 | 0 |